Article
Increased production of human granulocyte-macrophage colony stimulating factor (hGM-CSF) by the addition of stabilizing polymer in plant suspension cultures.
Basic Science Research Institute, Chonbuk National University, Dukjindong 664-14, Chonju, Chonbuk 561-756, South Korea.
Journal of Biotechnology (impact factor:
3.05).
08/2002;
96(3):205-11.
pp.205-11
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Plant cell cultures for the production of recombinant proteins.
[show abstract] [hide abstract]
ABSTRACT: The use of whole plants for the synthesis of recombinant proteins has received a great deal of attention recently because of advantages in economy, scalability and safety compared with traditional microbial and mammalian production systems. However, production systems that use whole plants lack several of the intrinsic benefits of cultured cells, including the precise control over growth conditions, batch-to-batch product consistency, a high level of containment and the ability to produce recombinant proteins in compliance with good manufacturing practice. Plant cell cultures combine the merits of whole-plant systems with those of microbial and animal cell cultures, and already have an established track record for the production of valuable therapeutic secondary metabolites. Although no recombinant proteins have yet been produced commercially using plant cell cultures, there have been many proof-of-principle studies and several companies are investigating the commercial feasibility of such production systems.Nature Biotechnology 12/2004; 22(11):1415-22. · 23.27 Impact Factor -
Article: Recombinant cytokines from plants.
[show abstract] [hide abstract]
ABSTRACT: Plant-based platforms have been successfully applied for the last two decades for the efficient production of pharmaceutical proteins. The number of commercialized products biomanufactured in plants is, however, rather discouraging. Cytokines are small glycosylated polypeptides used in the treatment of cancer, immune disorders and various other related diseases. Because the clinical use of cytokines is limited by high production costs they are good candidates for plant-made pharmaceuticals. Several research groups explored the possibilities of cost-effective production of animal cytokines in plant systems. This review summarizes recent advances in this field.International Journal of Molecular Sciences 01/2011; 12(6):3536-52. · 2.60 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
4.6-fold increase
cell suspension culture
cell suspension cultures
day 5
Gelatin
glycoprotein
GM-CSF
Granulocyte-macrophage colony-stimulating factor
human GM-CSF
initiation
maximum GM-CSF concentration
mid-exponential growth phase
natural mammalian leader sequences
polyethylene glycol
secreted GM-CSF
white blood cells